Regulatory FDA freezes CRL trove as ‘radical transparency’ push hits speedbump BioSpaceAn unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy...Read full story pharminent July 9, 2026 (Last updated: July 9, 2026) BioSpace An unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy… Read full story Post navigation Previous: NICE aims to cut funding for Amgen lung cancer drug LumykrasNext: GSK ends dementia alliance with Alector after setbacks Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026